MapLight Therapeutics, Inc.
MPLT
$20.55
$0.613.06%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 15.38% | 1.62% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 2.72% | 30.25% | |||
| Operating Income | -2.72% | -30.25% | |||
| Income Before Tax | 1.43% | -33.60% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 1.43% | -33.60% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 1.43% | -33.60% | |||
| EBIT | -2.72% | -30.25% | |||
| EBITDA | -2.73% | -30.60% | |||
| EPS Basic | 4.93% | -33.35% | |||
| Normalized Basic EPS | 5.55% | -34.22% | |||
| EPS Diluted | 4.93% | -33.35% | |||
| Normalized Diluted EPS | 5.55% | -34.22% | |||
| Average Basic Shares Outstanding | 3.67% | 0.20% | |||
| Average Diluted Shares Outstanding | 3.67% | 0.20% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||